INVESTMENT (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Mar. 31, 2023 |
Jun. 30, 2022 |
|
| ILiAD Biotechnologies, LLC [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Aggregrate investment | $ 7,000,000 | $ 7,000,000 | |||
| Book value of the investment | $ 4,612,000 | $ 4,612,000 | |||
| Iliad [Member] | Class C Units [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Ownership percentage not fully diluted | 6.80% | 6.80% | |||
| Iliad [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Aggregrate investment | $ 7,000,000 | $ 7,000,000 | |||
| Equity investment net loss | 391,000 | $ 355,000 | 1,065,000 | $ 788,000 | |
| ILiAD additional comprehensive loss | $ 621,000 | ||||
| Allocated share of additional loss | $ 42,000 | $ 42,000 | |||
| Iliad [Member] | Class C Units [Member] | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Ownership percentage fully diluted | 6.10% | ||||